Imuran Tablet
Product Images NDC 54766-590

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Imuran (NDC 54766-590). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sebela Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Ca59010001 Imuran

Ca59010001 Imuran
This is the description for a medication called "Imuran" (azathioprine) that comes in the form of tablets, with a strength of 50 mg per tablet. The medication should be kept out of reach of children and stored at room temperature (20°to 25°C) in a light-resistant container. The package contains 100 tablets. The inactive ingredients include acose, magpesium, starle, pat starch, povidone, and stz 200. The usual dosage should be as instructed in the package insert. The medication is distributed by Sebela and the package includes a lot number and expiration date.*
FDA Label Image

Package Label (Lb59010001)

Package Label (Lb59010001)
This text contains information related to a medicine named "IMURAN" (AZATHIOPRINE) TABLET, which comes in scored tablet form with 100 Tablets. The medicine is distributed by Sebela Pharmaceuticals Inc. from their address at 645 Hembree Parkway, Suite |, Roswell, GA 30076. The text also contains some numbers like "BESRE3", "S3Eos2", "5582", "5588", and "822%3" with some special characters like "=" and "£". There seem to be some unreadable characters as well. The purpose of these numbers and characters is not clear from the text. The text may be incomplete or not properly formatted.*
FDA Label Image

Structural Formula (Imu01 0003 01)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.